Metropolis Healthcare Statistics
Total Valuation
Metropolis Healthcare has a market cap or net worth of INR 115.78 billion. The enterprise value is 116.62 billion.
Market Cap | 115.78B |
Enterprise Value | 116.62B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Metropolis Healthcare has 51.24 million shares outstanding. The number of shares has increased by 0.19% in one year.
Shares Outstanding | 51.24M |
Shares Change (YoY) | +0.19% |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | 18.82% |
Owned by Institutions (%) | 50.13% |
Float | 25.40M |
Valuation Ratios
The trailing PE ratio is 84.85 and the forward PE ratio is 60.37. Metropolis Healthcare's PEG ratio is 3.38.
PE Ratio | 84.85 |
Forward PE | 60.37 |
PS Ratio | 9.30 |
PB Ratio | 10.56 |
P/FCF Ratio | n/a |
PEG Ratio | 3.38 |
Enterprise Valuation
EV / Earnings | 85.15 |
EV / Sales | 9.38 |
EV / EBITDA | 40.41 |
EV / EBIT | 56.54 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.18 |
Debt / EBITDA | 0.68 |
Debt / FCF | n/a |
Interest Coverage | 9.73 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 10.10% |
Revenue Per Employee | 2.88M |
Profits Per Employee | 317,569 |
Employee Count | 4,313 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.46% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +52.46% |
50-Day Moving Average | 2,133.70 |
200-Day Moving Average | 1,880.61 |
Relative Strength Index (RSI) | 60.85 |
Average Volume (20 Days) | 133,017 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Metropolis Healthcare had revenue of INR 12.44 billion and earned 1.37 billion in profits. Earnings per share was 26.63.
Revenue | 12.44B |
Gross Profit | 9.68B |
Operating Income | 2.06B |
Pretax Income | 1.87B |
Net Income | 1.37B |
EBITDA | 2.26B |
EBIT | 2.06B |
Earnings Per Share (EPS) | 26.63 |
Balance Sheet
The company has 1.16 billion in cash and 1.97 billion in debt, giving a net cash position of -810.24 million or -15.81 per share.
Cash & Cash Equivalents | 1.16B |
Total Debt | 1.97B |
Net Cash | -810.24M |
Net Cash Per Share | -15.81 |
Equity (Book Value) | 10.99B |
Book Value Per Share | 213.98 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 77.81%, with operating and profit margins of 16.58% and 11.01%.
Gross Margin | 77.81% |
Operating Margin | 16.58% |
Pretax Margin | 15.00% |
Profit Margin | 11.01% |
EBITDA Margin | 18.20% |
EBIT Margin | 16.58% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.17%.
Dividend Per Share | 4.00 |
Dividend Yield | 0.17% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.19% |
Shareholder Yield | -0.01% |
Earnings Yield | 1.18% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |